{"id":1442,"date":"2008-03-13T09:56:45","date_gmt":"2008-03-13T09:56:45","guid":{"rendered":"https:\/\/kweaver.org\/diabetes\/update-1-abbott\/"},"modified":"2008-03-13T09:56:45","modified_gmt":"2008-03-13T09:56:45","slug":"update-1-abbott","status":"publish","type":"post","link":"https:\/\/kweaver.org\/diabetes\/update-1-abbott\/","title":{"rendered":"UPDATE 1-Abbott gets FDA OK on glucose monitoring system | Reuters"},"content":{"rendered":"<p style=\"margin-bottom: 0\">Finally.&#160; Anyone who has followed this blog for a long time will remember I&#8217;ve been waiting on this for YEARS.&#160;If it is cost competive, I will try it. <\/p>\n<p style=\"margin-top: 0; margin-bottom: 0;\">&#160;<\/p>\n<p style=\"margin-top: 0; margin-bottom: 0;\">Quoted from <cite>http:\/\/www.reuters.com\/article\/companyNews\/idUSN1327658820080313<\/cite>:<\/p>\n<p style=\"margin-top: 0; margin-bottom: 0;\">&#160;<\/p>\n<blockquote style=\"margin-top: 0; margin-bottom: 0;\">\n<p style=\"margin-top: 0\"><a href=\"http:\/\/www.reuters.com\/article\/companyNews\/idUSN1327658820080313\"> UPDATE 1-Abbott gets FDA OK on glucose monitoring system | Reuters <\/a><\/p>\n<p><!--StartFragment--><br \/>\nAbbott Laboratories Inc (ABT.N: <a href=\"http:\/\/www.reuters.com\/stocks\/quote?symbol=ABT.N\">Quote<\/a>, <a href=\"http:\/\/www.reuters.com\/stocks\/companyProfile?symbol=ABT.N\">Profile<\/a>, <a href=\"http:\/\/www.reuters.com\/stocks\/researchReports?symbol=ABT.N\">Research<\/a>) said on Thursday it   won U.S. regulatory approval for its continuous glucose monitoring system for   people with diabetes.<br \/>\n<!--EndFragment-->\n<\/p><\/blockquote>\n","protected":false},"excerpt":{"rendered":"<p>Finally.&#160; Anyone who has followed this blog for a long time will remember I&#8217;ve been waiting on this for YEARS.&#160;If it is cost competive, I will try it. &#160; Quoted from http:\/\/www.reuters.com\/article\/companyNews\/idUSN1327658820080313: &#160; UPDATE 1-Abbott gets FDA OK on glucose monitoring system | Reuters Abbott Laboratories Inc (ABT.N: Quote, Profile, Research) said on Thursday it [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1442","post","type-post","status-publish","format-standard","hentry","category-blog"],"_links":{"self":[{"href":"https:\/\/kweaver.org\/diabetes\/wp-json\/wp\/v2\/posts\/1442","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kweaver.org\/diabetes\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kweaver.org\/diabetes\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kweaver.org\/diabetes\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kweaver.org\/diabetes\/wp-json\/wp\/v2\/comments?post=1442"}],"version-history":[{"count":0,"href":"https:\/\/kweaver.org\/diabetes\/wp-json\/wp\/v2\/posts\/1442\/revisions"}],"wp:attachment":[{"href":"https:\/\/kweaver.org\/diabetes\/wp-json\/wp\/v2\/media?parent=1442"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kweaver.org\/diabetes\/wp-json\/wp\/v2\/categories?post=1442"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kweaver.org\/diabetes\/wp-json\/wp\/v2\/tags?post=1442"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}